Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Recruiting · NCT04812366 · Registry updated 2026-08-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-08-14 | NCT04812366 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Inc. | 6 |
| University Health Network, Toronto | 417 |
| University of British Columbia | 284 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center | Boston | United States | 1 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| London Health Sciences Centre | London | Canada | 58 |
| Ottawa Hospital Research Institute (OHRI) | Ottawa | Canada | 1 |
| U.T. MD Anderson Cancer Center | Houston | United States | 7 |
| University Health Network | Toronto | Canada | 50 |
| University of California Davis | Sacramento | United States | 34 |
| University of Michigan Health | Ann Arbor | United States | 1 |
| Vancouver Prostate Centre | Vancouver | Canada | 6 |